Results 221 to 230 of about 3,636,929 (290)

Nuclear Alpha‐Synuclein in Parkinson’s Disease and the Malignant Transformation in Melanoma

María E. Jiménez‐Capdeville, Érika Chi-Ahumada, Francisco García-Ortega, Juan Pablo Castanedo-Cázares, Robert A. Norman, Ildefonso Rodríguez‐Leyva   +5 more
openalex   +1 more source

Benign to malignant progression in cervical squamous epithelium

, 1994
K.G.G. Keijser
openalex   +1 more source

NR4A1 Exerts Pro‐Tumor Role in Glioblastoma via Inducing xCT/GPX4‐Regulated Ferroptosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Purpose This study investigates NR4A1's paradoxical roles in glioblastoma (GBM) progression, focusing on its mechanistic link to ferroptosis regulation. We aimed to resolve conflicting reports of NR4A1 as both an oncogene and a tumor suppressor by defining its transcriptional control over xCT/GPX4‐mediated iron homeostasis and its clinical ...
Peng Tao, Shikuan Din, Zhengkang Fu, Qian Sun, Xiwei Zhu, Yuxin Wei, Huan Qu, Xinyi Zhang, Jiaxuan Liu, Chuhua Fu, Qianxue Chen   +10 more
wiley   +1 more source

Early GLP-1 Agonist Use and Cancer Risk in Type 2 Diabetes: A Real-World Data Cohort Study. [PDF]

Oncol Res
Chuang CH, Tsai PK, Kao SW, Wang YH, Yeh CB.   +4 more
europepmc   +1 more source

A Study on Radiosensitivity Cell Line SSM-1 Derived Human Oral Malignant Melanoma.

, 1995
Masafumi Mimura
openalex   +2 more sources

Interleukin‐6 as a Key Biomarker in Facioscapulohumeral Dystrophy: Evidence From Longitudinal Analyses

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is a progressive neuromuscular disorder with no approved treatments. Identifying reliable biomarkers is critical to monitor disease severity, activity, and progression. Interleukin‐6 (IL‐6) has been proposed as a candidate biomarker, but longitudinal validation is limited ...
Jonathan Pini, Emanuela Martinuzzi, Sandra Dhifallah, Abderhmane Slioui, Angela Puma, Luisa Villa, Michele Cavalli, Andra Ezaru, Jérémy Garcia, Manuela Gambella, Federico Torre, Luca Jacopo Pavan, Nicolas Glaichenhaus, Sabrina Sacconi   +13 more
wiley   +1 more source

A case of malignant fibrous histiocytoma (MFH).

, 2000
Toshiaki Yanagi, Toshihiro Sato, Susumu Takayasu, Yuji Asada, Sotaro Kurata, Masao Chujo, Takashi Miura, Seiji Yoshida, Shigeo Yokoyama   +8 more
openalex   +2 more sources

Clinical Characteristics and Outcomes of Early‐Onset Versus Late‐Onset LGI1‐Antibody Encephalitis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Leucine‐rich glioma‐inactivated 1 antibody (LGI1‐Ab) encephalitis predominantly affected older individuals, but has also been reported in younger patients. However, the demographic, clinical, and prognostic characteristics of early‐onset LGI1‐Ab encephalitis have yet to be systematically elucidated. This study aims to systematically
Yu Kong, Shasha Yu, Jing Zhang, Yu Zu, Yujing Zhang, Jing Lv, Xuyang Cao, Xuedan Feng   +7 more
wiley   +1 more source

Malignant Transformation Associated with Endometrioid Adenocarcinoma of Abdominal Wall Endometriosis: A Case Report and Literature Review. [PDF]

Int Med Case Rep J
Wei M, Liu W, Zheng Z, Liu Y, Zhang X.
europepmc   +1 more source

Frontier of Radiotherapy for Malignant Brain Tumors

, 2006
Shin‐Ichi Miyatake
openalex   +2 more sources